Hauck & Aufhaeuser analyst Alexander Galitsa maintained a Buy rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price ...
Carl Zeiss Meditec reported a fall in net profit for the first quarter of fiscal 2025 despite a slight uptick in revenue, as it warned of a continuing challenging macroeconomic environment.
Here’s how it works. Zeiss binoculars provide quality and reliability and with their Carl Zeiss lenses, they deliver a sharper image with less chromatic aberration. Of course, with this kind of ...
On the financial side, Goldman Sachs has made modest upward revisions to its estimates for Carl Zeiss Meditec. EBITA forecasts have been raised by 0-3% for FY25-27, driven by higher expected revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results